Browse by author
Lookup NU author(s): Dr Jae Ho Lee, Dr Parisa Javadian Elyaderani, Dr Hamid Reza Soleimanpour Lichaei, Professor Craig Robson, Professor Karim Nayernia
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Cancer stem cell studies may improve understanding of tumor pathophysiology and identify more effective strategies for cancer treatment. In a variety of organisms, Piwil2 has been implicated in multiple roles including stem cell self-renewal, RNA silencing, and translational control. In this study, we documented specific expression of the stem cell protein Piwil2 in breast cancer with predominant expression in breast cancer stem cells. In patients who were evaluated, we determined that 90% of invasive carcinomas and 81% of carcinomas in situ exhibited highest expression of Piwil2. In breast cancer cells, Piwil2 silencing suppressed the expression of signal transducer and activator of transcription 3, a pivotal regulator of Bcl-X-L and cyclin D1, whose downregulation paralleled a reduction in cell proliferation and survival. Our findings define Piwil2 and its effector signaling pathways as key factors in the proliferation and survival of breast cancer stem cells. Cancer Res; 70(11); 4569-79. (c) 2010 AACR.
Author(s): Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schutte D, Shoukier M, Karimi-Busheri F, Weinfeld M, Rasouli-Nia A, Hengstler JG, Mantilla A, Soleimanpour-Lichaei HR, Engel W, Robson CN, Nayernia K
Publication type: Article
Publication status: Published
Journal: Cancer Research
Year: 2010
Volume: 70
Issue: 11
Pages: 4569-4579
Print publication date: 11/05/2010
ISSN (print): 0008-5472
ISSN (electronic): 1538-7445
Publisher: American Association for Cancer Research
URL: http://dx.doi.org/10.1158/0008-5472.CAN-09-2670
DOI: 10.1158/0008-5472.CAN-09-2670
Altmetrics provided by Altmetric
